To explore suitable drugs for HCC patients with high expression of PRDX1, we used the oncoPredict R package in testing the sensitivity of drugs between two groups with differing PRDX1 expression levels, based on Cancer Therapeutics Response Portal (http://portals.broadinstitute.org/ctrp.v2.1/) and Genomics of Drug Sensitivity in Cancer (https://www.cancerrxgene.org/) databases (Figure 12D). This evidence concerns the gene PRDX1 and cancer.